Every report the desk has filed, searchable by full text, topic, format, symbol and date range.
Dozens of transcripts and results decks from Orora, Aumovio, Japan Display, Stratec, iHeartMedia and OPAL Fuels underscore a fragmented, idiosyncratic reporting session
With no dominant macro catalyst, the session was defined by a broad small- and mid-cap earnings flow spanning European industrials, Japanese display manufacturing, US media and renewable fuels, leaving index-level direction to AI infrastructure headlines.
Direct presidential participation in next week's session raises the stakes for market-structure rules, prediction-market legitimacy and digital asset policy
Sources indicate President Trump is expected to attend a White House meeting bringing together chief executives from the crypto, prediction market and artificial intelligence industries, signaling continued executive-level engagement on digital asset and event-contract regulation.
Snowflake, Rhythm Pharmaceuticals and Krystal Biotech executives lead more than $40 million in disclosed disposals, with Dutch Bros the rare insider buy
A dense cluster of Form 4 filings shows heavy insider distribution across software and biotechnology, led by a $16.8 million Snowflake director sale and roughly $15.5 million of combined Rhythm Pharmaceuticals executive sales, while insider buying was limited to a single Dutch Bros board purchase.
Report that Nvidia has scaled down its guarantee tied to OpenAI's compute buildout revives scrutiny of circular vendor financing underpinning the AI capex cycle
Nvidia is reported to have reduced the scope of a roughly $250 billion guarantee supporting OpenAI-linked data center construction, a move that shifts financing risk back toward developers, lenders and OpenAI itself and challenges the market's assumption that chip-vendor balance sheets will underwrite the next leg of AI infrastructure.
Wesdome and Aya Gold & Silver report into a firm bullion backdrop while analysts argue Albemarle retains upside with lithium at $20 per kilogram, as Stellantis weighs a Brampton plant sale amid union talks.
A cluster of resource-sector results and revised commodity assumptions point to improving cash generation across precious metals and lithium, even as automotive restructuring underscores that downstream demand remains uneven.
The crossover manager's latest disclosures show reduced mega-cap technology exposure alongside a new position in SpaceX, illustrating how public-market crowding is pushing institutional capital into late-stage private assets.
Tiger Global Management cut stakes across mega-cap technology holdings while establishing an allocation to SpaceX, a reallocation that mirrors broader institutional discomfort with public AI valuations and growing appetite for privately held frontier assets.
The Chicago Fed president says recent inflation prints show genuine improvement, a dovish tilt that lands as risk assets wobble and rate-sensitive sectors search for a policy anchor.
Chicago Fed President Austan Goolsbee said recent inflation data shows improvement, marking one of the more constructive assessments from a sitting policymaker in recent weeks and reviving expectations for a more accommodative path.
A broad de-rating across AI hardware names sends Broadcom lower and pushes KLA into upgrade territory, while BofA flags 16 beaten-down AI-linked stocks spanning hardware, internet and power infrastructure.
The AI trade entered a fresh drawdown phase, with Broadcom leading declines and a punishing July for semiconductor capital equipment names. Sell-side desks are now differentiating between valuation resets and genuine demand deterioration, with KLA upgraded on weakness and BofA circulating a list of 16 oversold AI-linked names.
Small-cap capital raises and narrative-driven equities absorbed the session's heaviest damage, while a valuation critique argued Rivian's market capitalization cannot be justified against Stellantis.
YXT.Com Group collapsed 35% on a dilutive equity offering and Trump Media & Technology fell 18% for the week, underscoring a punishing funding environment for story stocks. Separately, research questioned why Rivian commands a market value comparable to Stellantis, while microcaps including bioAffinity Technologies and RentGuarantor drew small-scale financing and stake-building activity.
Derivatives flow diverged from spot as traders bought protection into unconfirmed take-private speculation at Workday and faded a 7% Copart rally.
Unusual options activity in Workday signals institutional hedging around reported Silver Lake takeover interest, while Copart's contract flow turned defensive despite a 7% advance in the shares. The pairing points to derivatives markets pricing event risk and mean reversion rather than directional conviction.
Credicorp beat on rising ROE and Intercorp Financial screens at a discount, while Brazilian consumer and reinsurance names posted the season's defining pattern — profitability up, revenue soft.
A coordinated wave of Q2 2026 reports from Latin American issuers showed profitability improving even as revenue and premium lines contracted. Credicorp topped estimates with a higher return on equity, Intercorp Financial Services was flagged as strongly profitable at a valuation discount, and Grupo Mateus, M. Dias Branco, Cyrela and IRB all delivered mixed prints where margins or EPS beat while sales fell short.
Research flow across the AI complex hardened into two camps this session — buy-side conviction in compute infrastructure earnings power versus valuation fatigue in second-derivative names like Vicor and Nebius.
A dense batch of sell-side and independent research reframed the AI capital-expenditure debate: Meta's spending shock is being characterized as transitory, Applied Materials is described as firing on all cylinders, and one Wall Street shop sees more than 60% upside in Broadcom after a three-month drawdown. Offsetting that, Vicor's power opportunity is judged already priced in and Nebius' $40bn backlog is met with skepticism.
A concentrated round of reiterations tied to regulatory milestones, patent litigation and quarterly execution underscores that small-cap biotech is being underwritten on catalysts rather than sector beta.
H.C. Wainwright reiterated constructive ratings on four clinical and commercial-stage biotechs on the same session, citing regulatory progress at Pharvaris, a $36 target on 4D Molecular, patent-suit developments at Cytokinetics and a strong quarter at CorMedix.
Storage names catch a bid on tightening supply and data-center demand while optical component suppliers give back gains, exposing a widening valuation gap inside the AI infrastructure chain.
Western Digital advanced sharply as investors reprice storage economics tied to AI workloads, while Coherent's post-earnings sell-off is being defended as justified on valuation — a sign the AI supply-chain trade is now discriminating between links.
Goldman Sachs downgrades Douglas after a weak Q3 marred by competitive intensity, while Birkenstock slides and European e-commerce names post uneven results — evidence the consumer trade is fragmenting by brand and price point.
A cluster of European consumer results and sell-side actions points to deteriorating pricing power and intensifying rivalry in beauty, footwear and online retail, even as Lowe's and select U.S. retailers head into a pivotal reporting week.
Bullion consolidates historic highs while volatility drains out of both crypto and traditional markets, leaving U.S.-Iran risk and swelling sovereign debt as the market's main unpriced tail risks.
Gold is holding firmly above $4,400 an ounce after a softer inflation print strengthened the case for policy easing, even as realized volatility across crypto and TradFi collapses to unusually subdued levels. Strategists warn the calm masks live geopolitical and fiscal risks.
S&P Global, Netflix, Rubrik and Intercontinental Exchange sit at the center of an investor argument over whether artificial intelligence erodes information moats or deepens them.
Research flow is coalescing around a single strategic question: does generative AI disintermediate incumbent data and content platforms, or does proprietary distribution and regulated infrastructure make them the primary beneficiaries? Current valuations for S&P Global and Netflix suggest the market is pricing the bear case.
Bernstein lifts Wayfair on a revenue growth outlook while Macquarie upgrades DiDi Global on improved earnings, with two Outperform-rated Chinese EV names added to the conviction list.
Research desks are re-rating cyclically exposed consumer and Chinese mobility equities, signalling growing confidence that the earnings trough is behind these names. The clustering of upgrades across Wayfair, DiDi and Chinese EV manufacturers points to a coordinated shift in sell-side risk appetite.
A dense cluster of Q2 and Q1 FY27 results — Navamedic, Sea1 Offshore, SATS, Alicon Castalloy and CS TECH Ai — reveals a clear bifurcation between companies harvesting mix and those absorbing input costs.
The latest wave of small- and mid-cap reporting shows margin expansion decoupling from revenue growth. Navamedic posted a 380bp gross margin surge on flat sales, SATS converted mix into 25% EPS growth, while Alicon Castalloy hit record revenue with compressed margins — a textbook divergence in operating leverage quality.
Bitcoin nurses losses amid a cluster of headwinds as ETF flows dry up and traditional risk markets offer no offsetting bid, leaving altcoin liquidity dangerously thin.
Digital assets are under coordinated pressure as a deteriorating regulatory backdrop combines with anemic spot ETF creations and a risk-neutral equity tape. XRP's slide toward the $1 threshold marks a psychologically important level for the broader altcoin complex.